A Philadelphia jury awarded $6 million in punitive damages and $3.45 million in compensatory damages Monday to a woman who was diagnosed with breast cancer after taking Wyeth's hormonal drug Prempro. According to plaintiffs counsel, the case is the first in the United States involving a plaintiff diagnosed with breast cancer well after the July 2002 release of the Women's Health Initiative, a randomized, controlled trial of the risks and benefits of hormone replacement.
Philadelphia Jury Awards $9.45 Million in Damages Over Prempro Drug
The Legal Intelligencer
February 23, 2010